← FDA DRUG APPROVALS

FDA ANDA · ANDA075508

PSORCON

diflorasone diacetate

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA075508
TYPE
ANDA
ORIGINAL APPROVAL
2000-04-24
LATEST ACTION
2016-07-28
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

DIFLORASONE DIACETATEPrescription
DIFLORASONE DIACETATE 0.05% · CREAM · TOPICAL

Approval history

2016-07-28Labeling · Supplement 14 · standardAP
2016-07-28Labeling · Supplement 13 · standardAP
2001-10-15Manufacturing (CMC) · Supplement 2AP
2000-12-29Manufacturing (CMC) · Supplement 1AP
2000-04-24OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →